UNICREDIT BANK/PUT/ABBVIE/180/0.1/18.09.24 Stock

Warrant

DE000HD6JCC7

Real-time BOERSE MUENCHEN 15:42:26 2024-07-01 EDT
1.16 EUR -0.85% Intraday chart for UNICREDIT BANK/PUT/ABBVIE/180/0.1/18.09.24

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-01 1.16 -0.85%
24-06-28 1.17 -7.14%
24-06-27 1.26 +20.00%
24-06-26 1.05 -5.41%
24-06-25 1.11 +11.00%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 03:42 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD6JCC
ISINDE000HD6JCC7
Date issued 2024-06-24
Strike 180 $
Maturity 2024-09-18 (79 Days)
Parity 10 : 1
Emission price 1.22
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.27
Lowest since issue 1
Delta-0.69x
Omega 9.449
Premium1.54x
Gearing13.6x
Moneyness 1.058
Difference Strike 9.63 $
Difference Strike %+5.35%
Spread 0.01
Spread %0.85%
Theoretical value 1.155
Implied Volatility 21.09 %
Total Loss Probability 27.83 %
Intrinsic value 0.9004
Present value 0.2546
Break even 167.60 €
Theta-0.02x
Vega0.03x
Rho-0.02x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
171.5 USD
Average target price
183.2 USD
Spread / Average Target
+6.83%
Consensus